Neena Kadaba
Direttore/Membro del Consiglio presso Eyevensys SAS
Profilo
Neena Kadaba is currently a Director at Eyevensys SAS since 2020.
Prior to this, she worked as a Partner at Mission Bay Capital Management, Inc. from 2014 to 2015.
Dr. Kadaba completed her undergraduate and graduate degrees from Massachusetts Institute of Technology in 2003 and received her doctorate degree from California Institute of Technology in 2008.
Posizioni attive di Neena Kadaba
| Società | Posizione | Inizio |
|---|---|---|
Eyevensys SAS
 Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Direttore/Membro del Consiglio | 08/01/2020 |
Precedenti posizioni note di Neena Kadaba
| Società | Posizione | Fine |
|---|---|---|
Mission Bay Capital Management, Inc.
 Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Investitore di Private Equity | 31/12/2015 |
Formazione di Neena Kadaba
| Massachusetts Institute of Technology | Graduate Degree |
| California Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Mission Bay Capital Management, Inc.
Mission Bay Capital Management, Inc. Investment ManagersFinance Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California. | Finance |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Commercial Services |
- Borsa valori
- Insiders
- Neena Kadaba
